PDL
GILD icon

Portfolio Design Labs’s Gilead Sciences GILD Stock Holding History

Portfolio Design Labs’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
10,178
+341
+3% +$44.9K 0.21% 96
2026
Q1 		$1.37M Sell
9,837
-2,542
-21% -$356K 0.24% 81
2025
Q4 		$1.52M Buy
12,379
+231
+2% +$28.1K 0.25% 100
2025
Q3 		$1.35M Buy
+12,148
New +$1.38M 0.23% 116
2024
Q1 		– Sell
-3,660
Closed -$296K – 124
2023
Q4 		$296K Buy
+3,660
New +$285K 0.11% 98

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Portfolio Design Labs's GILD Position: Q2 2026 in Review

Portfolio Design Labs increased its Gilead Sciences (GILD) stake by 3.5% in Q2 2026, buying an estimated $44.9K and bringing the position to 10,178 shares worth $1.29M. The position accounts for 0.21% of the portfolio, ranked #96.

Portfolio Design Labs first reported a position in GILD in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.52M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Portfolio Design Labs held 10,178 shares of Gilead Sciences worth $1.29M as of Q2 2026.
  • Portfolio Design Labs bought 341 Gilead Sciences shares in Q2 2026, an estimated $44.9K.
  • Gilead Sciences made up 0.21% of Portfolio Design Labs's portfolio in Q2 2026, its #96 holding.
  • Portfolio Design Labs first reported a position in Gilead Sciences in Q4 2023 and has held it in 5 quarters since.
  • Portfolio Design Labs's Gilead Sciences position peaked at $1.52M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.